JPMorgan offers 1.60× accelerated barrier notes due Jul 13, 2029
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
JPMorgan Chase Financial Company LLC is offering Uncapped Accelerated Barrier Notes linked to the lesser performing of the Dow Jones Industrial Average® and the Nasdaq-100 Index®, due July 13, 2029, fully and unconditionally guaranteed by JPMorgan Chase & Co.
The notes are designed to deliver at least 1.60× of any appreciation of the lesser performing index at maturity, pay no interest or dividends, and expose investors to principal loss if the lesser performing index falls below a 70.00% barrier of its initial value. The notes are expected to price on or about July 10, 2026 and settle on or about July 15, 2026; minimum denomination is $1,000. The estimated value at pricing would be approximately $970 per $1,000 note and will not be less than $950 per $1,000 note.
Insights
Product mixes leveraged upside with full downside exposure below a 70% barrier.
The notes provide an Upside Leverage Factor of 1.60 on the lesser performing index while capping neither upside nor issuer return; however, if the lesser performing index falls below 70.00% of its Initial Value, holders suffer an equivalent percentage loss of principal.
Secondary market liquidity is limited and pricing reflects selling commissions and internal funding; prospective purchasers should weigh the $970 estimated value versus the original issue price and consider credit exposure to both JPMorgan Financial and JPMorgan Chase & Co..
Tax treatment is expected to be as an open transaction, but it is subject to confirmation by tax counsel.
The issuer expects these notes to be treated as open transactions for U.S. federal income tax purposes, which would generally produce long-term capital gain/loss treatment if held over a year; this position is not binding on the IRS.
Section 871(m) analysis is noted and the issuer expects it not to apply to these notes; purchasers should consult their tax advisers and await the pricing‑date tax opinion.
Key Figures
Key Terms
Upside Leverage Factor financial
Barrier Amount financial
open transactions regulatory
Section 871(m) regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What is the maturity and guarantee on AMJB structured notes?
How is the payout on AMJB notes determined at maturity?
What are the expected pricing and estimated value for the notes?
Do these notes pay interest or dividends before maturity?
What liquidity and secondary market should I expect for AMJB notes?
AI-generated analysis. How Rhea-AI works. Not financial advice.




